Introduction of p53 induces cell-cycle arrest in p53-deficient human medullary-thyroid-carcinoma cells

International Journal of Cancer

Volumn 73, Issue 3, 1997, Pages 449-455

  Velasco, Juan A ^a   Medina, Diego L ^a   Romero, Jesús ^b   Eugenia Mato, M ^c   Santisteban, Pilar ^a,d  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOMA CELL; CELL VIABILITY; EXON; GENE REARRANGEMENT; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; TUMOR GROWTH;

BLOTTING, SOUTHERN; CARCINOMA, MEDULLARY; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE REARRANGEMENT; GENES, P53; HUMANS; RETROVIRIDAE; THYROID NEOPLASMS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030664005     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971104)73:3<449::AID-IJC21>3.0.CO;2-6     Document Type: Article

References (28)

1. ANDREWS, N.C. and FALLER, D.V., A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19, 249 (1991).
2. CAJOT, J.F., ANDERSON, M.J., LEHMAN, T.A., SHAPIRO, H., BRIGGS, A.A. and STANBRIDGE, E.J., Growth suppression mediated by transfection of p53 in Hut292DM human lung-cancer cells expressing endogenous wild-type p53 protein. Cancer Res., 52, 6956-6960 (1992).
3. CASEY, G., LO-HSUEH, M., LOPEZ, M.E., VOGELSTEIN, B. and STANBRIDGE, E.J., Growth suppression of human breast-cancer cells by the introduction of a wild-type p53 gene. Oncogene, 6, 1791-1797 (1991).
4. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid-guanidinium-thiocyanatc-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
5. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, E., KINZLER, K.W. and VOGELSTEIN, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
6. ELLEDGE, R.M. and LEE, W.H., Life and death by p53. BioEssays, 17, 923-930 (1995).
7. FAGIN, J.A., MATSUO, K., KARMAKAR, A., CHEN, D.L., TANG, S.H. and KOEFFLER, H.P., High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J. clin Invest., 91, 179-184 (1993).
8. FAGIN, J.A., TANG. S.H., ZEKI, K., DI LAURO, R., FUSCO, A. and GONSKY, R., Re-expression of thyroid peroxidase in a derivative of an undifferentiated thyroid-carcinoma cell line by introduction of wild-type p53. Cancer Res., 56, 765-771 (1996).
9. FARID, N.R., SHI, Y. and ZOU, M., Molecular basis of thyroid cancer, Endocrine Rev., 15, 202-232 (1994).
10. FELGNER, P.L., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M. and DANIELSEN, M., Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. nat. Acad. Sci. (Wash.), 84, 7413-7417 (1987).
11. 1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
12. HARRIS, M.P., SUTJIPTO, S., WILLS, K.M., HANCOCK, W., CORNELL, D.C., JOHNSON, D.E., GREGORY, R.J., SHEPARD, H.M. and MANEVAL, D.C., Adenovirus-mediated gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Their., 3, 121-130 (1996).
13. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancers. Science, 253, 49-53 (1991).
14. HOLM, R. and NESLAND, J.M., Retinohlastoma and p53-tumor-suppressor-gene-protein expression in carcinomas of the thyroid gland. J. Pathol., 17, 267-272 (1994).
15. ITO, T., SEYAMA, T., MIZUNO, T., TSUYAMA, N., HAYASHI, T., HAYASHI, Y. DOHI, K., NAKAMURA, N. and AKIYAMA, M., Unique association of p53 mutations with undifferentiated but not differentiated carcinomas of the thyroid gland. Cancer Res., 52, 1369-1371 (1992).
16. LEONG, S.S., HOROSZEWICZ, J.S., SHIMAOKA, K., FRIEDMAN, M., KAWINSKI, E., SONG, M.J., ZEIGEL, R., CHU, T.M., BAYLIN, S.B. and MIRAND, E.A., A new cell line for study of human medullary thyroid carcinoma. In: M. Andreoli, K Monaco and J. Robbins (eds.). Advances in thyroid neoplasia, pp. 95-108. Field Educational Italia, Rome (1981).
17. MATOZAKI, T., SAKAMOTO, C., SUZUKI, T., MATSUDA, K., UCHIDA, T., NAKANO, O., WADA, K., NISHISAKI, H., KONDA, Y., NAGAO, M. and KASUGA, M., p53 gene mutations in human gastric cancer: wild-type hut not mutant p53 suppresses growth of human gastric-cancer cells. Cancer Res., 52, 4335-4341 (1992).
18. 1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res., 55, 2075-2080 (1995).
19. NELKIN, B.D., DE BUSTOS, A., MABRY, M. and BAYLIN, S.B., The molecular biology of thyroid carcinoma: a model for cancer development and progression. J, Amer., med. Ass., 261, 3130-3135 (1989).
20. NIGRO, J.M. and 15 OTHERS, Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.), 342, 705-708 (1989).
21. NODA, A., NING, Y., VENABLE, S.F., PERKIRA-SMITH, O.M. and SMITH, J.R., Cloning of senescence-cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211, 90-98 (1994).
22. POLYAK, K., WALDMAN, T., HE, T.C., KINZLER, K.W. and VOGELSTEIN, B., Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10, 1945-1952 (1996).
23. SANTISTEBAN, P., ACEBRON, A., POLYCARPOU-SCHWARZ, M. and DI LAURO, R., Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol. Endocrinol., 6, 1310-1317 (1992).
24. SHERR, C.J., Cancer-cell cycles. Science, 274, 1672-1677 (1996).
25. WOODWORTH, C.D., WANG, H., SIMPSON, S., ALVAREZ-SALAS, L.M. and NOTARIO, V., Over-expression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human-papillomavirus-expressing cell linos. Cell Growth Differ., 4, 367-376 (1993).
26. WRIGHT, P.A., LEMOINE, N.R., GORETZKI, P.E., WYLLIE, F.S., BOND, J., HUGHES, C, ROHER, H.D., WILLIAMS, E.D. and WYNFORD-THOMAS, D., Mutation of the p53 gene in a differentiated human thyroid-carcinoma cell line, but not in primary thyroid tumors. Oncogens, 6, 1693-1697 (1991).
27. WYLLIE, F.S., HAUGHTON, M.F., BLAYDES, J.P., SCHLUMBERGER, M. and WYNFORD-THOMAS, D., Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells. Oncogene, 10, 49-59 (1995).
28. YANA, I., NAKAMURA, T., SHIN, E., KARAKAWA, K., KURAHASHI, H., KURITA, Y., KOBAYASHI, T., MORI, T., NISHISHO, I. and TAKAI, S., Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma. Jap. J. Cancer Res., 83, 1113-1116 (1992).